The Form 4 filing, an SEC report of insider stock trades, was filed on November 19, 2026. It lists August 12, 2026, as the earliest purchase date and October 5, 2026, as the latest.
The report covers 29 purchases by Yitzhak Nissan, an Eltek director. It also indicates a trading-plan reference, but the available details do not show which purchases it covers.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-08-12 |
| Date of Latest Transaction | 2026-10-05 |
| Buy/Sell | buy |
| Transaction Count | 29 |
| Shares Transacted | 258,982 |
| Price | $8.92 |
| Total Transaction Value | $2,311,089.72 |
| Insider | |
| Ticker Symbol | ELTK |
| Company | ELTEK LTD |
| Insider Name | Nissan Yitzhak |
| Insider Title | Director |
| Sector - Industry | Technology - Electronic Components |
| Holdings | |
| Total Shares Owned After Transaction | 4,054,866 |
| Position Size Change | 6.39% |
| Filing | |
| Filing Date | 2026-11-19 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were purchases of ELTK shares, reported with transaction code P.
What was the average price of the transaction?
The average purchase price was $8.92 per share, rounded to the nearest cent. Separate prices for each of the 29 purchases are not available here.
How did this transaction affect the insider's holdings?
The director bought 258,982 shares in these transactions. He reported owning 4,054,866 shares afterward. The newly bought shares made up 6.39% of that reported total.
What's the total transaction value?
The total purchase value was $2,311,089.72. That amount covers all 29 reported purchase transactions.
Are there any special circumstances around this transaction?
The available filing information indicates a Rule 10b5-1 trading-plan reference. These plans set trading instructions in advance. The plan details and filing footnotes are not available here. It is therefore unclear which of the 29 purchases the reference covers. The plan's start date, trading schedule, and other terms remain unknown.
For research purposes only; not investment advice.